Dubuque Bank & Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-3,093
Closed -$241K – 207
2019
Q4
$241K Buy
+3,093
New +$242K 0.04% 179
2019
Q2
– Sell
-2,607
Closed -$166K – 312
2019
Q1
$166K Sell
2,607
-1,506
-37% -$85.9K 0.03% 173
2018
Q4
$210K Buy
4,113
+1,698
+70% +$85.9K 0.04% 147
2018
Q3
$140K Sell
2,415
-24
-1% -$1.17K 0.02% 178
2018
Q2
$118K Hold
2,439
– – 0.02% 237
2018
Q1
$113K Buy
2,439
+24
+1% +$1.04K 0.02% 276
2017
Q4
$91K Buy
2,415
+1,965
+437% +$72.1K 0.01% 291
2017
Q3
$16K Hold
450
– – ﹤0.01% 432
2017
Q2
$18K Hold
450
– – ﹤0.01% 411
2017
Q1
$14K Hold
450
– – ﹤0.01% 459
2016
Q4
$14K Hold
450
– – ﹤0.01% 380
2016
Q3
$18K Hold
450
– – ﹤0.01% 336
2016
Q2
$15K Sell
450
-204
-31% -$6.98K ﹤0.01% 369
2016
Q1
$19K Buy
654
+390
+148% +$10.8K ﹤0.01% 343
2015
Q4
$7K Buy
+264
New +$6.86K ﹤0.01% 563
2014
Q1
– Sell
-600
Closed -$7K – 445
2013
Q4
$7K Hold
600
– – ﹤0.01% 378
2013
Q3
$7K Hold
600
– – ﹤0.01% 359
2013
Q2
$7K Buy
+600
New +$7.1K ﹤0.01% 313

Other funds holding EW

Dubuque Bank & Trust's EW Position: Q1 2020 in Review

Dubuque Bank & Trust sold out of Edwards Lifesciences (EW) in Q1 2020, closing a stake of 3,093 shares — an estimated $241K sold.

Dubuque Bank & Trust first reported a position in EW in Q2 2013 and held it in 18 quarters. The position peaked at $241K in Q4 2019. 1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.

  • Dubuque Bank & Trust reported no remaining Edwards Lifesciences position as of Q1 2020 after selling out during the quarter.
  • Dubuque Bank & Trust sold 3,093 Edwards Lifesciences shares in Q1 2020, an estimated $241K.
  • Dubuque Bank & Trust first reported a position in Edwards Lifesciences in Q2 2013 and held it in 18 quarters.
  • Dubuque Bank & Trust's Edwards Lifesciences position peaked at $241K in Q4 2019.
  • 1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on Dubuque Bank & Trust's 13F filing for Q1 2020, filed 21 Apr 2020.